Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 20,000 shares at $5.73 ($115K) on 2025-03-12, disclosed to the SEC on 2025-03-12.
Open-market sale of $115k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.73 | 10,000 | $57K | 50.0% |
| 2 | $5.73 | 10,000 | $57K | 50.0% |
| Total | $5.73 avg | 20,000 | $115K | 100% |
| Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |
| EBS | SELL | 2024-05-23 | $6K | — | Filing → |